GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Effective Interest Rate on Debt %

Sun Pharma Advanced Research Co (NSE:SPARC) Effective Interest Rate on Debt % : 6.75% (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Sun Pharma Advanced Research Co's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was ₹181.6 Mil. Sun Pharma Advanced Research Co's average total debt for the quarter that ended in Mar. 2025 was ₹2,689.2 Mil. Therefore, Sun Pharma Advanced Research Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 6.75%.


Sun Pharma Advanced Research Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Effective Interest Rate on Debt % Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.99 8.45 16.09 4.40 5.48

Sun Pharma Advanced Research Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.95 3.66 - - 6.75

Competitive Comparison of Sun Pharma Advanced Research Co's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharma Advanced Research Co's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's Effective Interest Rate on Debt % falls into.


;
;

Sun Pharma Advanced Research Co Effective Interest Rate on Debt % Calculation

Sun Pharma Advanced Research Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Mar. 2024 )+Total Debt  (A: Mar. 2025 ))/ count )
=-1  *  -90.4/( (611.51+2689.2)/ 2 )
=-1  *  -90.4/1650.355
=5.48 %

where

Total Debt  (A: Mar. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=106.609 + 504.901
=611.51

Total Debt  (A: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1069.4 + 1619.8
=2689.2

Sun Pharma Advanced Research Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  -181.6/( (0+2689.2)/ 1 )
=-1  *  -181.6/2689.2
=6.75 %

where

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1069.4 + 1619.8
=2689.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Sun Pharma Advanced Research Co  (NSE:SPARC) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Sun Pharma Advanced Research Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharma Advanced Research Co Business Description

Traded in Other Exchanges
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines